Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-05-27
2000-01-18
Brusca, John S.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C07H 2100
Patent
active
06015893&
ABSTRACT:
Oligonucleoside compounds useful in inhibiting expression of focal adhesion kinase protein in animals, and related methods and formulations for reducing cancer cell growth, invasion and metastasis. The compounds are selected to be complementary to a target region of a focal adhesion kinase nucleic acid sequence, preferably human FAK mRNA.
REFERENCES:
Andre et al., "Expression of an n-terminally truncated form of human focal adhesion kinase in brain", Biochemical and Biophysical Research Communications 190:140-147 (Jan. 1993).
Burridge et al., "Tyrosine Phosphorylation of Paxillin and pp125.sup.FAK Accompanies Cell Adhesion to Extracellular Matrix: A Role in Cytoskeletal Assembly", The Journal of Cell Biology, 119:4 893-903 (Nov. 1992).
Cance et al., "Novel Protein Kinases Expressed in Human Breast Cancer", Int. J. Cancer: 54:571-577 (Mar. 1993).
Chan et al., "In Vitro and in Vivo Consequences of VLA-2 Expression on Rhabdomyosarcoma Cells", Science 251:1600-1602 (Mar. 1991).
Cobb et al., "Stable of Association of pp60.sup.src and pp59.sup.fyn with the Focal Adhesion Protein Tyrosine Kinase, pp125.sup.FAK ", Mo. Cell. Biol., 14:147-155 (Jan. 1994).
Ezzell C., "Just the FAK(s), Ma'am: Researchers Investigate A New Signaling Enzyme", J. NIH Research 5:49-54 (Dec. 1993).
Frisch, et al., "Disruption of Epithelial Cell-Matrix Interactions Induces Apoptosis", J. Cell Biology, 124:619-626 (Feb. 1994).
Gehlsen, et al., "Intergrin expression in human melanoma cells with differing invasive and metastic properties", Clin. Exp. Metastasis 10:111-120 (Sep.--Nov. 1992).
Guan, et al., "Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein", clel Regulation 2:951-964 (Nov. 1991).
Guan, J.L. & Shalloway, D., "Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation", Nature 358:690-692 (Aug. 1992).
Hanks, et al., "Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin", Proc. Nat'l. Acad. Sci. USA 89:8489-8491 (Sep. 1992).
Hildebrand, et al., "Identification of Sequences Required for the Efficient Localization of the Focal Adhesion Kinase pp125.sup.FAK, to Cellular Focal Adhesions", J. Cell Biol. 123:993-1005 (Nov. 1993).
ILIC, et al., "Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mcie", Nature 377:539-544 (Oct. 1995).
Juliano, et al., "Adhesion Molecules in cancer: the role of integrins", J.A. Curr. Opin. Cell Biol. 5:812-818 (Oct. 1993).
Kornberg, et al., "Signal transduction by integrin: Increased protein tyrosine phosphorylation caused by clustering of .beta..sub.1 integrins", Proc. Nat'l. Acad. Sci. USA 88:8392-8396 (Oct. 1991).
Kornberg, et al., "Cell Adhesion or Integrin Clustering Increases Phosphorylation of a Focal Adhesion-associated Tyrosine Kinase", J. Biol. Chem. 267:23439-442 (Nov. 1992).
Liotta, et al., "Cancer Metastasis and Angiogenesis: An Imbalance of Positive and Negative Regulation", Cell 64:327-336 (Jan. 1991).
Lipfert et al., "Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets", Journal of Cell Biology 119:4 905-912 (Nov. 1992).
Neckers et al., "Antisense technology: biological utility and practical considerations", American Journal of Physiology 9:1 L1-L12 (Jul. 1993).
Ruiz, et al., "Suppression of Mouse Melanoma Metastasis by EA-1, A Monoclonal Antibody Specific for .alpha.6 Integrins", Cell Adhesion Commun. 1;67-81 (1993).
Schaller, et al., "Autonomous Expression of a Noncatalytic Domain of the Focal Adhesion-Associated Protein Tyrosine Kinase pp125.sup.FAK ", Mol. Cell Biol. 13:785-791 (Feb. 1993).
Schaller et al., "pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions", Proc. Natl. Acad. Sci. U.S.A. 89:5192-5196 (Jun. 1992).
Talamonti, et al., "Increase in Activity and Level of pp60.sup.c-src in Progressive Stages of Human Colorectal Cancer", J. Clin. Invest. 91:53-60 (Jan. 1993).
Varner, et al., "Ectopic expression of integrin .alpha..sup.5 .beta..sup.1 suppresses in vitro growth and tumorigenecity of human colon carcinoma cells", Mol. Biol. Cell 3:232A (Sep. 1992).
Weber, et al., "Differential pp60.sup.c-src Activity in Well and Poorly Differentiated Human Colon Carcinomas and Cell Lines", J. Clin. Invest. 90:815-821 (Sep. 1992).
Weiner et al., "Expression of focal adhesion kinase gene and invasive cancer", The Lancet 342:1024-1025 (Oct. 1993).
Weiner et al., "Expression of Growth Factor Receptors, the Focal Adhesion Kinase, and Other Tyrosine Kinases in Human Soft Tissue Tumors", Ann. Surg. Oncol. 1:18-27 (1994).
Whitney et al., "human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK", DNA and Cell Biology 12:9 823-827 (Nov. 1993).
Xing et al., "Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain", Molecular Biology of the Cell 5:413-421 (Apr. 1994).
Zachary, et al., "Focal Adhesion Kinase (p125.sup.FAK) : A Point of Convergence in the Action of Neuropeptides, Integrins, and Oncogenes", Cell 71:891-894 (Dec. 1992).
Zachary, et al., "Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in swiss 3T3 cells", J. Biol. Chem. 267:19031-34 (Sep. 1992).
Amersham Catalog. Amersham Corporation pp. 28 and 259, 1992.
Awgulewitsch e tal. Spatial restriction in expression of a nouse homeo box locus within the central nervous system. Nature vol. 320 pp. 328-335, 1986.
Milner et al. Selecting effective antisense reagents on combinatorial oligonucelotide arrays. Nature Biotechnology vol. 15, pp. 537-541, 1997.
Wagner et al. Potent and selective inhibition of gene expression by an antisense heptanucleotide Nature Biotechnology vol. 14 840-844, 1996.
Uhlmann et al. Antisense oligonucleotides: A new therapeutic principle Chemical reviews vol. 90 543-584. 1990.
Cance William G.
Liu Edison T.
Owens Lewis V.
Brusca John S.
The University of North Carolina at Chapel Hill
LandOfFree
Oligonucleoside compounds and methods for inhibiting tumor growt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleoside compounds and methods for inhibiting tumor growt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleoside compounds and methods for inhibiting tumor growt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-564215